Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
LONDON, Sept. 09, 2024 (GLOBE NEWSWIRE) — Treos Bio announced the results of a meta-analysis from three clinical trials evaluating…
September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to…
— Recorded First Quarter Revenue of $40.2 Million — — Signed $66 Million in Net New Business, Resulting in Backlog…
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage…
SUNNYVALE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
MacroGenics to host investor call to review key data presented at ESMO on Monday, September 16, 2024, at 8:00 a.m.…
Oslo, September 9, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the…
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday,…